Overview
Anaerobutyricum hallii (formerly Eubacterium hallii) is a strictly anaerobic, Gram-positive bacterium belonging to the family Lachnospiraceae within the phylum Firmicutes. Reclassified in 2018 by Shetty et al., it is a core member of the human gut microbiome that may be detected from the first months of life. This species is recognized for its versatile metabolic capabilities, particularly its ability to convert lactate, acetate, and glucose into butyrate and propionate, making it a central species in the gut trophic chain.
Classification
The genus Anaerobutyricum currently contains two species: A. hallii and A. soehngenii, both previously classified under Eubacterium hallii. Some literature treats them as closely related but distinct species. A. hallii belongs to the Lachnospiraceae family, which includes other important SCFA producers such as Roseburia intestinalis and Blautia obeum. The reclassification was based on detailed phylogenomic analyses that distinguished this lineage from the polyphyletic genus Eubacterium.
Key Characteristics
A. hallii is metabolically versatile, capable of utilizing glucose, lactate, acetate, glycerol, and 1,2-propanediol as substrates. It produces butyrate and propionate as primary fermentation end products and can also generate reuterin (3-hydroxypropionaldehyde), an antimicrobial compound active against various gut pathogens. Notably, A. hallii may transform the food carcinogen PhIP (a heterocyclic amine from cooked meat) via GDH-mediated acrolein production, potentially blocking its mutagenic activity. Its lactate clearance function may help prevent intestinal lactate accumulation, which is relevant in malabsorption syndromes.
Health Significance
Research suggests that A. hallii and the closely related A. soehngenii may offer meaningful metabolic health benefits. Clinical trials with the L2-7 strain of A. soehngenii have demonstrated improvements in insulin sensitivity in prediabetic and type 2 diabetes patients, potentially by reversing the elevated lactate levels characteristic of insulin resistance. The species may also contribute to cancer prevention through its ability to transform dietary carcinogens. As a key lactate-utilizing bacterium, it plays an important ecological role in maintaining gut metabolic balance alongside other butyrate producers like Faecalibacterium prausnitzii.